Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
51 other companies have their registered office at the same address; threshold 10.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
GASTRO - ENTEROLOGIE ET ENDOTHERAPIE from Anderlecht, company number BE0478643530, closed financial year 2025 with a result of € -29,589 after tax. For that financial year GASTRO - ENTEROLOGIE ET ENDOTHERAPIE recorded a gross margin of € -13,091 and equity of € 1.8 million. Compared with financial year 2024, the result moved from € 27,160 to € -29,589. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 27, 2026.
€ 1.8 million
▼ 2% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -29,589
▼ still € 27,160 profit in 2024
Profit after tax over the fiscal year.
€ 27,779
▼ 25% vs 2024
Cash and bank balances on the last day of the fiscal year.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 7,565
▲ 1% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -58,099 | € -112,381 | € -62,149 | € -13,091 | ▲ € 49,057 |
| Profit after taxes | € -70,585 | € -115,674 | € 27,160 | € -29,589 | ▼ € 56,749 |
| Equity | € 1,936,758 | € 1,821,084 | € 1,848,245 | € 1,818,656 | ▼ 2% |
| Total debts | € 3,774 | € 14,956 | € 10,651 | € 7,565 | ▼ 29% |
| Cash | € 105,273 | € 42,441 | € 37,115 | € 27,779 | ▼ 25% |
| Retained profit | € 1,593,544 | € 1,477,870 | € 1,505,030 | € 1,475,441 | ▼ 2% |
| Balance sheet total | € 1,940,532 | € 1,836,040 | € 1,858,895 | € 1,826,221 | ▼ 2% |
Key figures of GASTRO - ENTEROLOGIE ET ENDOTHERAPIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to GASTRO - ENTEROLOGIE ET ENDOTHERAPIE?
What happened at GASTRO - ENTEROLOGIE ET ENDOTHERAPIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Marianna ARVANITAKI stepped down as director. NBB
- Jacques DEVIERE stepped down as director. NBB
- Christophe MORENO stepped down as director. NBB
- Arnaud LEMMERS stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 29,589 (▼ € 56,749 vs 2024). Source: NBB ↗
- Marianna ARVANITAKI became a director. NBB
- Jacques DEVIERE became a director. NBB
- Christophe MORENO became a director. NBB
In short
From € 70,585 loss in 2022 to € 29,589 loss in 2025.
Best year ever: 2024, with € 27,160 profit.
A new publication or filing at GASTRO - ENTEROLOGIE ET ENDOTHERAPIE? We notify you, reason included.
Follow GASTRO - ENTEROLOGIE ET ENDOTHERAPIEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
Marianna ARVANITAKI
Director
since 2024 · until 2027
Jacques DEVIERE
Chairman of the board
Also active at: Brussels Medical Device Center, GIPHIC, Centre d'innovation médicale Michel Cremer/Marie Curie
since 2024 · until 2027
Christophe MORENO
Director
since 2024 · until 2027
Arnaud LEMMERS
Vice-chairman of the board
Also active at: Centre d'innovation médicale Michel Cremer/Marie Curie
since 2024 · until 2027
Establishments
Establishment units
Physical locations of this company
Lennikse Baan 808
1070 Anderlecht
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 51 companies are registered at this address.
All companies at this address →BELGISCHE FEDERATIE VAN HOGESCHOLEN VOOR KINESITHERAPIE - FEDERATION BELGE DES HAUTES ECOLES EN KINESITHERAPIE
Association des Médecins anciens Etudiants de l'université libre de Bruxelles
Association des Diplômés de l' école de santé publique de l'université de Bruxelles
Centre de Recherches et d'Etudes Appliquées de la Haute Ecole Libre de Bruxelles Ilya Prigogine
Crèche de l'Hôpital Erasme
€ 2.1 million revenue · 2025
+46 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0478.643.530
- VAT number
- BE 0478.643.530
- Registered office
- Lennikse Baan 808, 1070 Anderlecht
- Names & denominations
- GASTRO - ENTEROLOGIE ET ENDOTHERAPIE
- Enterprise type
- Rechtspersoon
- Legal form
- Non-profit association
- Legal situation
- Normale toestand
- Start date
- 16 September 2002
- Peppol
- Not registered